IBIO
IBIO
NASDAQ · Biotechnology

Ibio Inc

$1.26
+0.00 (+0.00%)
As of Sep 22, 4:50 PM ET ·
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Buy 13 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target +1,023.8% upside
Low Target $9.87
Average Target $14.16
High Target $18.59
Current Price $1.26
Current
$1.26
Target
$14.16
$9.87 $14.16 avg $18.59
Scenario Analysis
Bear Case
$9.87
683.3%
Low target
Base Case
$14.16
+1,023.8%
Avg target
Bull Case
$18.59
+1,375.4%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$3.82
-67.0% from high
52-Week Low
$0.77
+63.5% from low
Target vs 52W High
$14.16
+270.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.9%
AMGN
Amgen Inc
Hold 43 47% $190.87 -53.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.6%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -14.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
Hold 30 37% $149.45 -18.1%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -63.4%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -40.8%